# Andre Esteva

> Andre Esteva, PhD, is the co-founder and CEO of ArteraAI, a medical AI company whose test for personalizing prostate cancer therapy is included in NCCN clinical guidelines, reimbursed by Medicare, and deployed internationally. A Stanford-trained AI scientist whose Nature cover paper first demonstrated that AI could match dermatologists at diagnosing skin cancer, Esteva has co-founded four companies with a combined market cap of $2.2B. Named to TIME100 Health 2025 and Modern Healthcare's 40 Under 40 for 2025, he leads a company that raised $175M total and was named a TIME 2024 Best Invention.

- **Role:** Co-Founder and CEO at ArteraAI
- **Organizations:** ArteraAI, Silverback Capital Management, Cresta, Salesforce Research
- **Nationality:** American
- **Education:** BS in Electrical and Computer Engineering + Pure Mathematics (Engineering Valedictorian, Highest Honors), University of Texas at Austin, PhD in Electrical Engineering (Computer Vision / Artificial Intelligence), Stanford University
- **Known for:** Research cited 25,000+ times across publications, Published on covers of Nature and Nature Medicine - first AI to match clinician-level diagnostic accuracy, Co-founded 4 companies with combined market cap of $2.2B

## Career timeline

- **2011-2012** — Researcher at Sandia National Laboratories - computational nuclear fusion and metamaterials
- **2012-2017** — PhD at Stanford; research internship at Google Research (deep learning and computer vision)
- **2017** — Published landmark paper on AI dermatology diagnosis on the cover of Nature - first AI to match clinician-level performance
- **2017-2019** — Co-Founder & COO at Cresta (AI for contact centers; grew to $1.6B valuation)
- **2019** — Founded Silverback Capital Management (algorithmic AI trading strategies in micro-cap markets)
- **2019** — VC fellowships: EIR at Charles River Ventures, Fellow at Greylock X, Sequoia Capital, Accel Ventures
- **2019-2021** — Head of Medical AI at Salesforce Research
- **2021** — Co-founded ArteraAI with Dr. Felix Feng, with encouragement from Marc Benioff
- **2023** — ArteraAI launched publicly with $90M funding round led by Marc Benioff
- **2024** — ArteraAI raised additional $20M; named TIME 2024 Best Invention; FDA Breakthrough Device Designation
- **2025** — Named TIME100 Health 2025 and Modern Healthcare's 40 Under 40; ArteraAI Prostate received FDA de novo authorization; raised $65M additional round

## Achievements

- Research cited 25,000+ times across publications
- Published on covers of Nature and Nature Medicine - first AI to match clinician-level diagnostic accuracy
- Co-founded 4 companies with combined market cap of $2.2B
- Named TIME100 Health 2025 - one of the most influential people in health
- Modern Healthcare 40 Under 40, 2025
- 100 Most Influential People in Oncology 2025 (OncoDaily)
- ArteraAI named TIME 2024 Best Invention
- ArteraAI selected for World Economic Forum's Global Innovators program
- ArteraAI Prostate included in NCCN Clinical Practice Guidelines in Oncology
- ArteraAI Prostate received FDA de novo authorization - first AI tool to prognosticate long-term outcomes in localized prostate cancer
- ArteraAI Prostate Medicare-reimbursed and deployed internationally
- ArteraAI raised $175M total in funding
- Engineering Valedictorian at University of Texas at Austin

## Latest updates

- **2025-12** — ArteraAI raised $65M in its latest funding round, bringing total funding to $175M
- **2025-07** — FDA granted Breakthrough Device Designation to ArteraAI Prostate tool
- **2025-04** — Named to TIME100 Health 2025 list as one of the most influential people in health
- **2025-01** — Named to Modern Healthcare's 40 Under 40 for 2025
- **2025-01** — ArteraAI Prostate received FDA de novo authorization - first AI tool authorized for long-term outcome prognostication in localized prostate cancer
- **2024-12** — ArteraAI named TIME 2024 Best Invention
- **2024-02** — ArteraAI secured $20M additional funding for international expansion

## Links

- Website: https://www.andreesteva.com/
- LinkedIn: https://www.linkedin.com/in/andre-esteva-phd-ab6b2438/
- Twitter/X: https://twitter.com/andreesteva
- Instagram: https://www.instagram.com/andreesteva/

---

Profile page: https://yespress.io/andre-esteva
Published by YesPress — https://yespress.io
Last updated: 2026-05-07